Lyell Immunopharma Announces $80M Private Placement
Lyell Immunopharma says the private placement will advance Ronde-Cel toward a planned BLA submission.
Story updates
02:07:31 PM UTC
SquawkNews
Lyell Immunopharma agreed to sell 7,428,040 shares at $10.77 each for approximately $80M in gross proceeds, before fees and expenses. The financing is expected to extend cash runway into 2028; closing is expected on or about November 4, 2026, subject to customary conditions.Material DetailsContext…
02:09:37 PM UTC
SquawkNews
Lyell Immunopharma Announces $80 Million Private Placement to Advance Ronde-Cel Toward Planned BLA Submission